Characterization of an Intestinal Epithelial Cell Receptor Recognized by theCryptosporidium parvumSporozoite Ligand CSL
- 1 March 2001
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 69 (3) , 1661-70
- https://doi.org/10.1128/iai.69.3.1661-1670.2001
Abstract
The protozoan parasiteCryptosporidium parvumis a leading cause of diarrhea in humans and neonatal calves. The absence of approved parasite-specific drugs, vaccines, and immunotherapies for cryptosporidiosis relates in part to limited knowledge on the pathogenesis of zoite attachment and invasion. We recently reported that theC. parvumapical complex glycoprotein CSL contains a zoite ligand for intestinal epithelial cells which is defined by monoclonal antibody (MAb) 3E2. In the present study, the host cell receptor for CSL was characterized. For these studies, a panel of epithelial and mesenchymal cell lines was examined for permissiveness toC. parvumand the ability to bind CSL. Cells of epithelial origin were significantly more permissive and bound significantly greater quantities of CSL than cells of mesenchymal origin. Caco-2 intestinal cells were selected from the epithelial panel for further characterization of the CSL receptor. Immunoelectron microscopy demonstrated that CSL bound initially to the surface of Caco-2 cells and was rapidly internalized. The molecule bound by CSL was identified as an 85-kDa Caco-2 cell surface protein by radioimmunoprecipitation and CSL affinity chromatography. Sporozoite incubation with the isolated 85-kDa protein reduced binding of MAb 3E2. Further, attachment and invasion were significantly inhibited when sporozoites were incubated with the 85-kDa protein prior to inoculation onto Caco-2 cells. These observations indicate that the 85-kDa protein functions as a Caco-2 cell receptor for CSL. CSL also bound specifically to intestinal epithelium from calves, indicating receptor expression in a second important host species. Molecular characterization of the CSL receptor may lead to novel avenues for disrupting ligand-receptor interactions in the pathogenesis ofC. parvuminfection.Keywords
This publication has 128 references indexed in Scilit:
- Passive Antibody Therapies: Progress and Continuing ChallengesClinical Immunology, 1999
- Molecular cloning and characterization of a novel acidic microneme protein (Etmic-2) from the apicomplexan protozoan parasite, Eimeria tenellaPublished by Elsevier ,1999
- Inhibition of complete development ofCryptosporidium parvum in Caco-2 cellsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1996
- Dual interaction of the malaria circumsporozoite protein with the low density lipoprotein receptor-related protein (LRP) and heparan sulfate proteoglycans.The Journal of Experimental Medicine, 1996
- Complete development ofCryptosporidium parvumin MDBK cellsFEMS Microbiology Letters, 1996
- Comparative development ofCryptosporidium parvum(Apicomplexa) in 11 continuous host cell linesFEMS Microbiology Letters, 1994
- Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria.The Journal of cell biology, 1979